These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30918960)

  • 1. NG2/CSPG4 in glioblastoma: about flexibility.
    Finocchiaro G; Pellegatta S
    Neuro Oncol; 2019 Jun; 21(6):697-698. PubMed ID: 30918960
    [No Abstract]   [Full Text] [Related]  

  • 2. Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets.
    Girolamo F; Dallatomasina A; Rizzi M; Errede M; Wälchli T; Mucignat MT; Frei K; Roncali L; Perris R; Virgintino D
    PLoS One; 2013; 8(12):e84883. PubMed ID: 24386429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
    Tsidulko AY; Kazanskaya GM; Kostromskaya DV; Aidagulova SV; Kiselev RS; Volkov AM; Kobozev VV; Gaitan AS; Krivoshapkin AL; Grigorieva EV
    Tumour Biol; 2017 Sep; 39(9):1010428317724282. PubMed ID: 28945172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas.
    Schiffer D; Mellai M; Boldorini R; Bisogno I; Grifoni S; Corona C; Bertero L; Cassoni P; Casalone C; Annovazzi L
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Furanodienone overcomes temozolomide resistance in glioblastoma through the downregulation of CSPG4-Akt-ERK signalling by inhibiting EGR1-dependent transcription.
    Chen L; Liu YC; Zheng YY; Xu J; Zhang Y; Liu WL; Li ZY; Huang GD; Li WP
    Phytother Res; 2019 Jun; 33(6):1736-1747. PubMed ID: 31006910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NG2/CSPG4 and progranulin in the posttraumatic glial scar.
    Schäfer MKE; Tegeder I
    Matrix Biol; 2018 Aug; 68-69():571-588. PubMed ID: 29054751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional roles of CSPG4/NG2 in chondrosarcoma.
    Jamil NS; Azfer A; Worrell H; Salter DM
    Int J Exp Pathol; 2016 Apr; 97(2):178-86. PubMed ID: 27292772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality.
    Tamburini E; Dallatomasina A; Quartararo J; Cortelazzi B; Mangieri D; Lazzaretti M; Perris R
    FASEB J; 2019 Mar; 33(3):3112-3128. PubMed ID: 30550356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutaredoxin 2 promotes SP-1-dependent CSPG4 transcription and migration of wound healing NG2 glia and glioma cells: Enzymatic Taoism.
    Wilms C; Lepka K; Häberlein F; Edwards S; Felsberg J; Pudelko L; Lindenberg TT; Poschmann G; Qin N; Volbracht K; Prozorovski T; Meuth SG; Kahlert UD; Remke M; Aktas O; Reifenberger G; Bräutigam L; Odermatt B; Berndt C
    Redox Biol; 2022 Feb; 49():102221. PubMed ID: 34952462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell surface chondroitin sulphate proteoglycan 4 (CSPG4) binds to the basement membrane heparan sulphate proteoglycan, perlecan, and is involved in cell adhesion.
    Tang F; Lord MS; Stallcup WB; Whitelock JM
    J Biochem; 2018 May; 163(5):399-412. PubMed ID: 29462330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High chondroitin sulfate proteoglycan 4 expression correlates with poor outcome in patients with breast cancer.
    Hsu NC; Nien PY; Yokoyama KK; Chu PY; Hou MF
    Biochem Biophys Res Commun; 2013 Nov; 441(2):514-8. PubMed ID: 24177010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chondroitin sulfate proteoglycan protein is stimulated by interleukin 11 and promotes endometrial epithelial cancer cell proliferation and migration.
    Winship A; Van Sinderen M; Heffernan-Marks A; Dimitriadis E
    Int J Oncol; 2017 Mar; 50(3):798-804. PubMed ID: 28098860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia.
    Pucciarelli D; Lengger N; Takacova M; Csaderova L; Bartosova M; Breiteneder H; Pastorekova S; Hafner C
    Int J Oncol; 2015 Jul; 47(1):81-90. PubMed ID: 25997619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proximity Labeling by a Recombinant APEX2-FGF1 Fusion Protein Reveals Interaction of FGF1 with the Proteoglycans CD44 and CSPG4.
    Zhen Y; Haugsten EM; Singh SK; Wesche J
    Biochemistry; 2018 Jul; 57(26):3807-3816. PubMed ID: 29812912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors.
    Farnedi A; Rossi S; Bertani N; Gulli M; Silini EM; Mucignat MT; Poli T; Sesenna E; Lanfranco D; Montebugnoli L; Leonardi E; Marchetti C; Cocchi R; Ambrosini-Spaltro A; Foschini MP; Perris R
    BMC Cancer; 2015 May; 15():352. PubMed ID: 25935541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human melanoma/NG2 chondroitin sulfate proteoglycan is expressed in the sarcolemma of postnatal human skeletal myofibers. Abnormal expression in merosin-negative and Duchenne muscular dystrophies.
    Petrini S; Tessa A; Carrozzo R; Verardo M; Pierini R; Rizza T; Bertini E
    Mol Cell Neurosci; 2003 Jun; 23(2):219-31. PubMed ID: 12812755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human recombinant Fab fragment from combinatorial libraries of a B-cell lymphoma patient recognizes core protein of chondroitin sulphate proteoglycan 4.
    Egami Y; Narushima Y; Ohshima M; Yoshida A; Yoneta N; Masaki Y; Itoh K
    J Biochem; 2018 Jan; 163(1):61-68. PubMed ID: 29036679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSPG4 as Target for CAR-T-Cell Therapy of Various Tumor Entities-Merits and Challenges.
    Harrer DC; Dörrie J; Schaft N
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NG2 chondroitin sulfate proteoglycan: role in malignant progression of human brain tumours.
    Chekenya M; Rooprai HK; Davies D; Levine JM; Butt AM; Pilkington GJ
    Int J Dev Neurosci; 1999; 17(5-6):421-35. PubMed ID: 10571405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolating subpopulations of human epidermal basal cells based on polyclonal serum against trypsin-resistant CSPG4 epitopes.
    Gunnarsson AP; Christensen R; Praetorius J; Jensen UB
    Exp Cell Res; 2017 Jan; 350(2):368-379. PubMed ID: 28011196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.